Chronic rosiglitazone treatment restores AMPKalpha2 activity in insulin-resistant rat skeletal muscle (Q40381962)

20 September 2017

Chronic rosiglitazone treatment restores AMPKalpha2 activity in insulin-resistant rat skeletal muscle (English)

1 reference

20 September 2017

1 reference

1 reference

Bruce E Kemp

7

0 references

John A. Hawley

object named as

John A Hawley

8

0 references

author name string

Sarah J Lessard

1

1 reference

20 September 2017

Zhi-Ping Chen

2

1 reference

20 September 2017

Matthew J Watt

3

1 reference

20 September 2017

Michael Hashem

4

1 reference

20 September 2017

Julianne J Reid

5

1 reference

20 September 2017

Mark A Febbraio

6

1 reference

20 September 2017

23 August 2005

1 reference

American Journal of Physiology - Endocrinology and Metabolism

20 September 2017

1 reference

20 September 2017

290

1 reference

20 September 2017

2

1 reference

20 September 2017

E251-7

1 reference

PPARgamma, the ultimate thrifty gene

20 September 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00096.2005

Direct thiazolidinedione action on isolated rat skeletal muscle fuel handling is independent of peroxisome proliferator-activated receptor-gamma-mediated changes in gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00096.2005

Expression of uncoupling protein-3 mRNA in rat skeletal muscle is acutely stimulated by thiazolidinediones: an exercise-like effect?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00096.2005

Impaired fatty acid metabolism in type 2 diabetic skeletal muscle cells is reversed by PPARgamma agonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00096.2005

Impaired activation of AMP-kinase and fatty acid oxidation by globular adiponectin in cultured human skeletal muscle of obese type 2 diabetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00096.2005

AMPK signaling in contracting human skeletal muscle: acetyl-CoA carboxylase and NO synthase phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00096.2005

Skeletal muscle basal AMP-activated protein kinase activity is chronically elevated in alloxan-diabetic dogs: impact of exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00096.2005

Intensified exercise training does not alter AMPK signaling in human skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00096.2005

Thiazolidinediones: a new class of antidiabetic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00096.2005

The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00096.2005

Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00096.2005

Rosiglitazone but not metformin enhances insulin- and exercise-stimulated skeletal muscle glucose uptake in patients with newly diagnosed type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00096.2005

Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00096.2005

AMPK activity and isoform protein expression are similar in muscle of obese subjects with and without type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00096.2005

Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00096.2005

5'-AMP-activated protein kinase phosphorylates IRS-1 on Ser-789 in mouse C2C12 myotubes in response to 5-aminoimidazole-4-carboxamide riboside

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00096.2005

Direct derivation of conditionally immortal cell lines from an H-2Kb-tsA58 transgenic mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00096.2005

Rosiglitazone enhances glucose tolerance by mechanisms other than reduction of fatty acid accumulation within skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00096.2005

AMP-activated protein kinase (AMPK) is activated in muscle of subjects with type 2 diabetes during exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00096.2005

Metformin Increases AMP-Activated Protein Kinase Activity in Skeletal Muscle of Subjects With Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00096.2005

Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00096.2005

A comparison of three methods of glycogen measurement in tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00096.2005

Increased beta-oxidation in muscle cells enhances insulin-stimulated glucose metabolism and protects against fatty acid-induced insulin resistance despite intramyocellular lipid accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00096.2005

Thiazolidinediones inhibit lipoprotein lipase activity in adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00096.2005

Lactate content and pH in muscle samples obtained after dynamic exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00096.2005

Series introduction: the molecular and physiological basis of insulin resistance: emerging implications for metabolic and cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00096.2005

Thiazolidinediones in the treatment of insulin resistance and type II diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00096.2005

AMP-activated protein kinase is not down-regulated in human skeletal muscle of obese females

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00096.2005

AMP-activated protein kinase activates transcription of the UCP3 and HKII genes in rat skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00096.2005

Effects of chronic AICAR treatment on fiber composition, enzyme activity, UCP3, and PGC-1 in rat muscles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00096.2005

Role of PP2C in cardiac lipid accumulation in obese rodents and its prevention by troglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00096.2005

Increased fatty acid oxidation in transgenic mice overexpressing UCP3 in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00096.2005

5'AMP activated protein kinase expression in human skeletal muscle: effects of strength training and type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00096.2005

10.1152/AJPENDO.00096.2005

21 January 2018

Identifiers

DOI

1 reference

20 September 2017

1 reference